Skip to Main Content

News Center


$1.6 Million Grant Examines Impact of Antipsychotic Drug Reductions in Long-Term Care Facilities

August 22, 2019

Research team led by Dr. Linda Wastila aims to understand how a nationwide effort to reduce the use of antipsychotic medications in long-term care facilities has impacted those facilities’ use of other medications and patient health outcomes.

JAMA Study Examines Medicaid Oversight of Antipsychotic Use in Children

March 3, 2015

Study led by PHSR faculty member shows that 31 states have implemented prior authorization policies for atypical antipsychotic prescribing.

Study Confirms Rise in Antipsychotic Treatment of Medicaid-insured Children

March 15, 2013

More benefit/risk information is needed in community care efforts, says School of Pharmacy researcher.

2012-2013 UM-CERSI Awards Announced

December 7, 2012

The University of Maryland Center of Excellence in Regulatory Science and Innovation (UM-CERSI) recently awarded two Innovation Awards and two Innovations in Minority Health Awards to recognize pioneering research initiatives in regulatory science.